Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:30 PM
Ignite Modification Date:
2025-12-24 @ 9:30 PM
NCT ID:
NCT06459232
Eligibility Criteria:
Inclusion criteria
* With 1 or more claims of siponimod or MS-related FDA-approved DMT during the index calendar year. The date of first claim was the index date.
* With 1 or more MS diagnosis for 12 months prior to the index date \[inclusive\].
* Were continuously enrolled in pharmacy and medical benefits for 12 months prior to the index date \[inclusive\].
* Include patients who were 18 years or older on the index date.
* Include patients continuously enrolled in pharmacy and medical benefits from the index date \[inclusive\] to 6 months/12 months post-index date.
Exclusion criteria
• Patients with 1 or more claims of index drug within 12 months prior to index date.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06459232
Study Brief:
Protocol Section:
NCT06459232